NCT07853066

Brief Summary

Pre-workout supplements are widely used by physically active individuals to enhance exercise performance. These products typically contain stimulant substances such as caffeine, beta-alanine, arginine, and tyrosine, which act on the cardiovascular and central nervous systems. Although their ergogenic effects are well established, their safety profile - particularly regarding cardiac arrhythmias during exercise - has not been thoroughly investigated. This study aimed to evaluate whether the acute ingestion of a commercially available multi-ingredient pre-workout supplement (V-FORT® ULTRA, Vitafor, Brazil) could trigger cardiac arrhythmias during a treadmill exercise stress test in young, physically active adults. A randomized, double-blind, placebo-controlled crossover design was used. Participants underwent two exercise stress tests separated by 3 to 10 days: a familiarization test (Day 1) and an intervention test (Day 2), in which they received either the pre-workout supplement or a placebo beverage. Neither the participants nor the research team conducting the test were aware of the allocated intervention until after test completion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 3, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 3, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 3, 2026

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

September 27, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 1, 2026

Completed
Last Updated

October 1, 2026

Status Verified

September 1, 2026

Enrollment Period

6 months

First QC Date

September 27, 2026

Last Update Submit

September 27, 2026

Conditions

Keywords

Supplementation during endurance performance

Outcome Measures

Primary Outcomes (1)

  • Occurrence of Cardiac Arrhythmias During the Exercise Stress Test

    Presence or absence of cardiac arrhythmias identified on continuous 12-lead ECG during the treadmill exercise stress test and the 6-minute post-exercise recovery phase, compared between the pre-workout supplement and placebo conditions.

    During the treadmill exercise stress test and throughout the 6-minute post-exercise recovery phase (approximately 30 to 60 minutes per session, on Day 2)

Secondary Outcomes (2)

  • Haemodynamic Responses During the Exercise Stress Test

    At rest, during each stage of the treadmill exercise stress test, at peak effort, and during the 6-minute post-exercise recovery phase on Day 2

  • Exercise Stress Test Duration

    Day 1 (familiarization test) and Day 2 (intervention test), separated by 3 to 10 days

Study Arms (2)

Pre-Workout Supplement

EXPERIMENTAL

Participants received a single dose of V-FORT® ULTRA (Vitafor, Brazil), a multi-ingredient pre-workout supplement containing 200 mg caffeine, 2,000 mg beta-alanine, 1,000 mg arginine, 600 mg tyrosine, 300 mg phenylalanine, 415 mg carnitine, 1.9 g carbohydrate, vitamins (C, E, B6, B12) and minerals (sodium, magnesium, zinc); 8 kcal per 8 g sachet. The beverage was consumed up to 3 hours before the treadmill exercise stress test.

Dietary Supplement: Dietary Supplement

Placebo

PLACEBO COMPARATOR

Participants received a single dose of Tang® powdered juice (placebo), containing 2.6 g carbohydrate, 2.4 g sugars, 22 mg sodium, 1.1 mg zinc, 23 mg vitamin C, and 2.5 mcg vitamin D, with no stimulant substances. The beverage was prepared to be visually and organoleptically indistinguishable from the active supplement and was consumed up to 3 hours before the treadmill exercise stress test.

Dietary Supplement: Placebo

Interventions

Dietary SupplementDIETARY_SUPPLEMENT

Single dose of containing 200 mg caffeine, 2,000 mg beta-alanine, 1,000 mg arginine, 600 mg tyrosine, 300 mg phenylalanine, 415 mg carnitine, 1.9 g carbohydrate, vitamins (C, E, B6, B12) and minerals (sodium, magnesium, zinc); 8 kcal per 8 g sachet. Consumed up to 3 hours before the treadmill exercise stress test.

Pre-Workout Supplement
PlaceboDIETARY_SUPPLEMENT

Juice

Placebo

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18 to 30 years Both sexes Physically active, defined as engaging in at least 150 minutes of moderate-intensity physical activity or 75 minutes of vigorous-intensity physical activity per week, assessed by the International Physical Activity Questionnaire (IPAQ) Prior experience with pre-workout supplements (at least one previous use of any stimulant-based pre-workout supplement) No cardiac arrhythmias identified during the familiarization exercise stress test (Day 1)

You may not qualify if:

  • Presence of cardiac arrhythmias identified during the familiarization exercise stress test (Day 1) Physical inactivity (below the minimum physical activity thresholds on IPAQ) No prior use of any pre-workout or stimulant supplement Use of medications that may interfere with cardiovascular responses to exercise or supplementation Presence of known cardiovascular, metabolic, or musculoskeletal conditions that contraindicate exercise testing Orthopaedic limitations precluding treadmill exercise

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pro-Coracao

São Paulo, São Paulo, 05021-010, Brazil

Location

MeSH Terms

Interventions

Dietary Supplements

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The study beverage (pre-workout supplement or placebo) was prepared by a study nurse who was not part of the research or outcomes assessment team. The nurse was the only individual aware of the allocation. Participants, the exercise testing team, and the outcomes assessors remained blinded until after complete test execution.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Each participant completed two treadmill exercise stress tests separated by 3 to 10 days. On Day 1, a familiarization test was performed to assess baseline cardiac rhythm and exclude participants with pre-existing arrhythmias. On Day 2, participants were randomized (1:1) to receive either the pre-workout supplement or placebo, consumed up to 3 hours before the second exercise stress test. Both tests were performed at the same time of day. The sequence of conditions was determined by randomization, and allocation was concealed from both participants and the testing team until after test completion.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

September 27, 2026

First Posted

October 1, 2026

Study Start

March 3, 2026

Primary Completion

September 3, 2026

Study Completion

September 3, 2026

Last Updated

October 1, 2026

Record last verified: 2026-09

Locations